| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
6e-18 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
1e-16 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
4e-14 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
8e-14 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-13 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-12 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-12 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-11 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.35 |
5e-11 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
7e-11 |